X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (87) 87
index medicus (66) 66
humans (64) 64
breast cancer (59) 59
female (55) 55
obstetrics & gynecology (42) 42
middle aged (39) 39
further section (37) 37
adult (36) 36
chemotherapy (36) 36
cancer (33) 33
breast neoplasms - pathology (30) 30
prognosis (29) 29
breast neoplasms - drug therapy (26) 26
aged (25) 25
treatment outcome (22) 22
breast neoplasms - genetics (21) 21
neoadjuvant therapy (21) 21
survival (19) 19
gene expression (18) 18
neoplasm staging (18) 18
disease-free survival (17) 17
medicine & public health (17) 17
neoadjuvant chemotherapy (17) 17
care and treatment (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
research (15) 15
therapy (15) 15
analysis (14) 14
breast neoplasms - mortality (14) 14
tumors (14) 14
animals (13) 13
breast neoplasms - metabolism (13) 13
clinical information (13) 13
systemic therapy (13) 13
adjuvant treatment (12) 12
medical prognosis (12) 12
receptor, erbb-2 - metabolism (12) 12
chemotherapy, adjuvant (11) 11
paclitaxel (11) 11
research article (11) 11
surgery (11) 11
survival analysis (11) 11
early breast cancer (10) 10
genes (10) 10
local therapy (10) 10
risk factors (10) 10
biomarkers, tumor - metabolism (9) 9
breast neoplasms - therapy (9) 9
cyclophosphamide (9) 9
expression (9) 9
gene expression profiling (9) 9
gene expression regulation, neoplastic (9) 9
health aspects (9) 9
medicine (9) 9
preoperative chemotherapy (9) 9
treatment recommendations (9) 9
triple negative breast neoplasms - pathology (9) 9
aged, 80 and over (8) 8
doxorubicin (8) 8
estrogen-receptor (8) 8
follow-up (8) 8
genetic aspects (8) 8
hematology, oncology and palliative medicine (8) 8
identification (8) 8
kaplan-meier estimate (8) 8
metastatic breast cancer (8) 8
prospective studies (8) 8
receptors, estrogen - metabolism (8) 8
receptors, progesterone - metabolism (8) 8
retrospective studies (8) 8
risk (8) 8
studies (8) 8
subtypes (8) 8
targeted therapy (8) 8
triple-negative breast cancer (8) 8
young adult (8) 8
anthracyclines (7) 7
breast neoplasms - surgery (7) 7
cancer patients (7) 7
carboplatin (7) 7
expert discussion (7) 7
further section · weitere sektionen (7) 7
metastasis (7) 7
multivariate analysis (7) 7
mutation (7) 7
neurosciences (7) 7
oligonucleotide array sequence analysis (7) 7
pathology (7) 7
patients (7) 7
trastuzumab (7) 7
adjuvant chemotherapy (6) 6
anthracycline (6) 6
article (6) 6
biology (6) 6
biomarkers (6) 6
biomarkers, tumor - genetics (6) 6
carcinoma (6) 6
clinical trials (6) 6
endocrine therapy (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10087, pp. 2430 - 2442
Summary Triple-negative breast cancer is a heterogeneous disease and specific therapies have not been available for a long time. Therefore, conventional... 
Internal Medicine | TUMOR-INFILTRATING LYMPHOCYTES | BASAL-LIKE | MEDICINE, GENERAL & INTERNAL | ADENOID CYSTIC CARCINOMAS | NEOADJUVANT CHEMOTHERAPY | GENE-EXPRESSION | PHASE-II | SYNTHETIC LETHALITY | OPEN-LABEL | ADJUVANT BEVACIZUMAB | DOSE-DENSE DOXORUBICIN | Humans | Gene Expression Profiling - methods | Antineoplastic Agents - therapeutic use | Triple Negative Breast Neoplasms - drug therapy | Triple Negative Breast Neoplasms - immunology | Triple Negative Breast Neoplasms - genetics | Neoadjuvant Therapy - methods | Biomarkers, Tumor - metabolism | Female | Mutation | Genomics - methods | Ubiquitin-Protein Ligases - genetics | BRCA2 Protein - genetics | Molecular Targeted Therapy - methods | Lymphocytes, Tumor-Infiltrating - immunology | Medical research | Chemotherapy | RNA | Analysis | Stem cells | Medicine, Experimental | Breast cancer | Hormones, Sex | Angiogenesis inhibitors | Cancer | Androgens | Research institutes | Intervention | Therapy | State of the art | Mesenchyme | Androgen receptors | Homologous recombination | DNA damage | Medical services | Series (mathematics) | Clinical trials | Homology | Oncology | mRNA | Biology | Metastasis | Cancer therapies | Subgroups | Receptors | Alterations | Immunology | Signatures | Damage | Deoxyribonucleic acid--DNA | BRCA2 protein | BRCA1 protein | Markers | Gene expression | Biological activity | Inhibitors | Immune checkpoint | Breast | Tumors
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 609 - 618
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 8, pp. 1275 - 1281
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 10/2018, Volume 23, Issue S1, pp. 32 - 36
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 5/2012, Volume 19, Issue 5, pp. 1508 - 1516
Journal Article
Der Gynäkologe, ISSN 0017-5994, 12/2016, Volume 49, Issue 12, pp. 935 - 944
Die Bedeutung des axillären Stagings bei Patientinnen mit Mammakarzinom ist nicht abschließend geklärt. Wissenschaftliche Bemühungen konzentrieren sich... 
Neoadjuvant therapy | Neoadjuvante Therapie | Lymph node dissection | Gynecology | Sentinellymphknotenbiopsie | Breast cancer | Radiotherapy | Strahlentherapie | Medicine & Public Health | Obstetrics/Perinatology | Sentinel lymph node biopsy | Mammakarzinom | Lymphknotendissektion | Endocrinology
Journal Article
Der Gynakologe, ISSN 0017-5994, 12/2016, Volume 49, Issue 12, p. 935
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00129-016-3982-2 Die... 
Adjuvant treatment | Cancer
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2017, Volume 165, Issue 3, pp. 573 - 583
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2870 - 2878
Journal Article